Skip to Main Content

Paper Details

Comparison of the Adverse Event Profile of TheraSphere<sup>®</sup> with SIR-Spheres<sup>®</sup> for the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review.
Cardiovasc Intervent Radiol
33
2017
Author NameAffiliation
Kristian ThorlundMcMaster University
Kristian Thorlund
Edward J Mills
Edward J MillsStanford Prevention Research Center, Stanford School of Medicine, Stanford University
  • 1 - 4

Datasets

Release 1.2